Tara Heitner steps down as CEO of Cyxone
Cyxone (publ), a biotech in autoimmune diseases, announces that the company's Board has dismissed Tara Heitner from the company with immediate effect. Carl-Magnus Högerkorp, COO, will be acting as interim CEO.Tara Heitner has been the CEO at Cyxone since 2020. During this time, she has successfully developed the company from a virtual lean research company to a growing company with several clinical development projects which are engaging potential licensing partners. Carl-Magnus Högerkorp, COO and interim CEO at Cyxone, comments: “The company is currently facing an important phase in the